Key result
OCT-guided PCI links to improved clinical outcomes, benefiting small, long lesions the most.
Why the study?
The clinical impact of OCT-guided PCI based on lesion length and vessel diameter in complex coronary lesions remains unclear.
Does OCT-guided PCI reduce major adverse cardiac events compared to angiography-guided PCI in patients with complex coronary lesions?
RCT (n=1,604)
Randomized
Does OCT-guided PCI reduce major adverse cardiac events compared to angiography-guided PCI in patients with complex coronary lesions?
Answers are grounded in this paper and cite their sources.
OCT-guided PCI for complex lesions is associated with improved clinical outcomes compared to angiography guidance, particularly in long lesions (≥32 mm) with small reference vessel diameters (<2.8 mm).
BACKGROUND: The clinical impact of optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) based on lesion characteristics remains unclear. OBJECTIVES: This study aimed to assess the impact of OCT-guided PCI for complex lesions on clinical outcomes according to lesion length and reference vessel diameter (RVD). METHODS: In the OCCUPI (Optical Coherence Tomography-guided Coronary Intervention in Patients with Complex Lesions) trial, 1,604 patients with complex lesions were classified according to the median lesion length (32 mm) and RVD (2.8 mm) measured by quantitative coronary angiography. The primary endpoint was the 1-year incidence of major adverse cardiac events, a composite of cardiac death, myocardial infarction, stent thrombosis, or ischemia-driven target vessel revascularization. The median follow-up duration was 365 days (Q1-Q3: 365-365 days). RESULTS: The OCT guidance group showed a lower incidence of major adverse cardiac events than the angiography guidance group in patients with lesion length ≥32 mm (HR: 0.55; 95% CI: 0.32-0.95; P = 0.031) and RVD <2.8 mm (HR: 0.51; 95% CI: 0.28-0.92; P = 0.026). Across stratified groups based on lesion length and RVD, OCT guidance consistently demonstrated a direction of effect favoring OCT-guided PCI across all lesions (P for interaction = 0.526), with a particularly significant reduction in lesions ≥32 mm with RVD <2.8 mm (HR: 0.46; 95% CI: 0.23-0.94; P = 0.041). CONCLUSIONS: This post hoc analysis of the OCCUPI trial showed that clinical outcomes consistently favored OCT-guided PCI across varying lesion lengths and RVD, with the most pronounced benefit evident in lesions ≥32 mm with RVD <2.8 mm. (Optical CoherenCe Tomography-gUided Coronary Intervention in Patients With Complex lesIons: a Randomized Controlled Trial [OCCUPI Trial]; NCT03625908).
No takes yet. Share an insight, caveat, or question.
Roh et al. (2026) conducted an RCT in Complex coronary lesions (n=1,604). OCT-guided PCI vs. Angiography-guided PCI was evaluated on 1-year incidence of major adverse cardiac events (composite of cardiac death, myocardial infarction, stent thrombosis, or ischemia-driven target vessel revascularization) (HR 0.55, 95% CI 0.32-0.95, p=0.031). OCT-guided PCI reduced 1-year major adverse cardiac events vs angiography guidance in complex lesions ≥32 mm, with the greatest benefit if RVD <2.8 mm.
Synapse has enriched 10 related papers. Consider them for comparative context: